Recombinant CD276 (Omburtamab Biosimilar) antibody
Quick Overview for Recombinant CD276 (Omburtamab Biosimilar) antibody (ABIN7538077)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Omburtamab Biosimilar – Anti-CD276 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD276 (Omburtamab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research.
-
CAS-No
- 1895083-75-6
Target
-